<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>KVUE on FinanClub</title>
    <link>https://finan.club/tags/kvue/</link>
    <description>Recent content in KVUE on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sun, 06 Aug 2023 10:02:18 +0000</lastBuildDate><atom:link href="https://finan.club/tags/kvue/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>1153 KVUE</title>
      <link>https://finan.club/us/kvue/</link>
      <pubDate>Sun, 06 Aug 2023 10:02:18 +0000</pubDate>
      
      <guid>https://finan.club/us/kvue/</guid>
      <description>score:1153
Chances: Kenvue reported strong quarterly earnings, beating analyst estimates on both the top and bottom lines. The surge in heart procedures and higher demand for cold and flu medicines contributed to Johnson &amp;amp; Johnson&amp;rsquo;s solid gains in revenue and profit, which could also benefit Kenvue as its former consumer health unit.</description>
    </item>
    
  </channel>
</rss>
